Boston Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315M Buy
1,498,334
+636,081
+74% +$136M 0.28% 121
2026
Q1
$191M Buy
862,253
+230,929
+37% +$56.5M 0.2% 158
2025
Q4
$160M Sell
631,324
-11,215
-2% -$2.82M 0.17% 187
2025
Q3
$159M Buy
+642,539
New +$154M 0.16% 182

Other funds holding STE

Boston Partners's STE Position: Q2 2026 in Review

Boston Partners increased its Steris (STE) stake by 74% in Q2 2026, buying an estimated $136M and bringing the position to 1,498,334 shares worth $315M. The position accounts for 0.28% of the portfolio, ranked #121.

Boston Partners first reported a position in STE in Q3 2025 and has held it in 4 quarters since. 833 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Boston Partners held 1,498,334 shares of Steris worth $315M as of Q2 2026.
  • Boston Partners bought 636,081 Steris shares in Q2 2026, an estimated $136M.
  • Steris made up 0.28% of Boston Partners's portfolio in Q2 2026, its #121 holding.
  • Boston Partners first reported a position in Steris in Q3 2025 and has held it in 4 quarters since.
  • 833 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.